Abstract CT046: Phase I dose escalation study of the CDK4/6 inhibitor palbociclib in combination with the MEK inhibitor PD-0325901 in patients withRASmutant solid tumors
暂无分享，去创建一个
C. Paweletz | P. Jänne | Kwok-Kin Wong | G. Shapiro | A. Muzikansky | J. Supko | N. Chau | G. Oxnard | N. Feeney | J. Hilton | A. Wolanski | J. Cleary | B. Johnson | A. Anderson | Brian Beardslee | Leena Gandi | Faith Hassinger | K. Bhushan | Elizabeth Downey | Joseph W. Gibson | S. Pruitt-Thompson | S. Barry | Kwok-kin Wong